Macro drivers include ageing populations, post-pandemic stockpiling mandates, and emerging-market GDP growth; conversely, pricing pressure from group-purchasing coalitions and regulatory harmonisation (EU MDR, US FDA 510(k) tightening) force suppliers to de-feature or bundle services. North America remains the largest region, capturing 38 % of 2025 revenue, while South Asia & Pacific is the fastest-growing region with a 9 % CAGR as India, Indonesia, and Vietnam scale ICU bed capacity. Competitive intensity is rising as local assemblers in China and India undercut global incumbents, creating a bifurcated landscape where differentiation hinges on after-sales service uptime and data-driven clinical analytics.